Marie Reeberg Sass

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Venues

BMJ open

Acta psychiatrica Scandinavica

PloS one

This page only lists publications with an associated author ORCID identifier.

Publications

Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen, Ema Gruber, Helle Nerdrum, Lone Marianne Pedersen, Maximilian Resch, Troels Højsgaard Jørgensen, Claus Thorn Ekstrøm, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study. Acta psychiatrica Scandinavica 150 (1) (2024)
Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen, Ema Gruber, Helle Nerdrum, Lone Marianne Pedersen, Maximilian Resch, Troels Højsgaard Jørgensen, Claus Thorn Ekstrøm, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study. Acta psychiatrica Scandinavica (2024)
Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen, Ema Gruber, Helle Nerdrum, Lone Marianne Pedersen, Maximilian Resch, Troels Højsgaard Jørgensen, Claus Thorn Ekstrøm, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study. Acta psychiatrica Scandinavica 150 (1) (2024)
Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen, Ema Gruber, Helle Nerdrum, Lone Marianne Pedersen, Maximilian Resch, Troels Højsgaard Jørgensen, Claus Thorn Ekstrøm, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study. Acta psychiatrica Scandinavica 150 (1) (2024)
Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, Heidi Storgaard, Filip K Krag Knop, Mette Ødegaard Nielsen, Anders Mikael Sjödin, Ole Mors, Christoph U Correll, Claus Ekstrøm, Maj Vinberg, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry). BMJ open 13 (1) (2023)
Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, Heidi Storgaard, Filip K Krag Knop, Mette Ødegaard Nielsen, Anders Mikael Sjödin, Ole Mors, Christoph U Correll, Claus Ekstrøm, Maj Vinberg, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry). BMJ open 13 (1) (2023)
Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, Heidi Storgaard, Filip K Krag Knop, Mette Ødegaard Nielsen, Anders Mikael Sjödin, Ole Mors, Christoph U Correll, Claus Ekstrøm, Maj Vinberg, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry). BMJ open 13 (1) (2023)
Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, Heidi Storgaard, Filip K Krag Knop, Mette Ødegaard Nielsen, Anders Mikael Sjödin, Ole Mors, Christoph U Correll, Claus Ekstrøm, Maj Vinberg, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry). BMJ open 13 (1) (2023)
Marie Reeberg Sass, Tobias Søgaard Juul, Robert Skov, Kasper Iversen, Lene Holm Harritshøj, Erik Sørensen, Sisse Rye Ostrowski, Ove Andersen, Claus Thorn Ekstrøm, Henrik Ullum, Jimmi Nielsen, Ida Hageman, Anders Fink-Jensen
SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study. PloS one 17 (3) (2022)

Marie Reeberg Sass.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marie Reeberg Sass